{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:21:00Z","timestamp":1790806860102,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00555","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T04:21:46Z","timestamp":1588652506000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)"],"prefix":"10.3389","volume":"10","author":[{"given":"Abigail","family":"Pepin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Aghdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhradeep","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Ayoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Suy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional vs hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, Phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1002\/cncr.26067","article-title":"A survey of stereotactic body radiotherapy use in the United States","volume":"117","author":"Pan","year":"2011","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e188006","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low risk and intermediate risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw"},{"key":"B5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypogractionated vs conventionally fractionated radiotherapy for prostate cancer: 5-Year outcomes of the HYPO-RT-PC randomised, non-inferiority, Phase 3 Trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy vs stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from a international, randomized, open-label, Phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet"},{"key":"B7","unstructured":"ProstateEnlargement (Benign Prostatic Hyperplasia)\n          National Institute of Diabetes and Digestive and Kidney Diseases2014"},{"key":"B8","first-page":"1403","article-title":"Diagnosis and management of benign prostatic hyperplasia","volume":"77","author":"Edwards","year":"2008","journal-title":"Am Fam Phys"},{"key":"B9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of Transurethral Resection of Prostate (TURP) incidence, management, and prevention","volume":"50","author":"Rassweiler","year":"2006"},{"key":"B10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00345-010-0603-x","article-title":"Long-term urinary adverse effects of pelvic readiotherapy","volume":"29","author":"Elliott","year":"2011","journal-title":"World J Urol"},{"key":"B11","unstructured":"HoranN\n            CooperJS\n          Treasure Island (FL)StatPearls PublishingRadiation Cystitis And Hyperbaric Management2019"},{"key":"B12","first-page":"S26","article-title":"Alpha blockers for the treatment of prostatitis-like Syndromes","volume":"8","author":"Nickel","year":"2006","journal-title":"Rev Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2165\/00003495-200464210-00005","article-title":"Trospium chloride in the management of overactive bladder","volume":"64","author":"Rovner","year":"2004","journal-title":"Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0360-3016(99)00246-1","article-title":"Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot study","volume":"45","author":"Prosnitz","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.urology.2014.01.031","article-title":"Findings at cystoscopy performed for cause after prostate brachytherapy","volume":"83","author":"Leapman","year":"2014","journal-title":"Urology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0022-5347(05)65011-2","article-title":"Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia","volume":"167","author":"Kearney","year":"2002","journal-title":"J Urol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ctro.2017.09.005","article-title":"Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: a 10-year follow-up study of genitourinary toxicity in clinical practice","volume":"6","author":"Inokuchi","year":"2017","journal-title":"Clin Translat Radiat Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","article-title":"External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?","volume":"76","author":"Choe","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.prro.2019.04.003","article-title":"Safety of prostate stereotactic body radiation therapy after Transurethral Resection of the Prostate (TURP): a propensity score matched analysis","volume":"9","author":"Murthy","year":"2019"},{"key":"B20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.clon.2018.03.004","article-title":"Early results of extreme hypofractionation using stereotactic body radiation therapy for high risk, very high risk, and node positive prostate Cancer","volume":"30","author":"Murthy","year":"2018","journal-title":"Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1748-717X-8-58","article-title":"Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the georgetown experience","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/00005392-199904000-00112","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2011.00049","article-title":"Stereotactic body radiation therapy for low- and low-intermediate-risk prostate cancer: is there a dose effect?","volume":"1","author":"Katz","year":"2011","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ijrobp.2009.06.078","article-title":"External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity","volume":"77","author":"Devisetty","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.14338\/IJPT-15-00034.1","article-title":"Patient-reported quality of life in men with transurethral resection of the prostate undergoing proton therapy for management of prostate cancer","volume":"2","author":"Lee","year":"2016","journal-title":"Int J Part Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/j.1464-410X.2009.08664.x","article-title":"Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer","volume":"104","author":"Luo","year":"2009","journal-title":"BJU Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/COC.0b013e3182546821","article-title":"Is there an Increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy?","volume":"37","author":"Ishiyama","year":"2014","journal-title":"Am J of Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1748-717X-9-148","article-title":"Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer","volume":"9","author":"Chen","year":"2014","journal-title":"Radiat Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1748-717X-9-52","article-title":"Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer","volume":"9","author":"Bhattasali","year":"2014","journal-title":"Radiat Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fonc.2016.00122","article-title":"Acute urinary morbidity following stereotactic body radiotherapy for prostate cancer for prophylactic alpha-adrenergic antagonist and urethral dose reduction","volume":"6","author":"Repka","year":"2016","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/0360-3016(86)90283-X","article-title":"The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures","volume":"12","author":"Seymore","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1200\/JCO.2006.07.9954","article-title":"Patient and treatment factors associated with complications after prostate brachytherapy","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1748-717X-7-82","article-title":"Randomized Phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy","volume":"7","author":"Vainshtein","year":"2012","journal-title":"Radiat Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0360-3016(96)00570-6","article-title":"Low risk of urinary incontinence followng prostate brachytherapy in patients with a prior transurethral prostate resection","volume":"37","author":"Wallner","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T04:21:48Z","timestamp":1588652508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":37,"alternative-id":["10.3389\/fonc.2020.00555"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00555","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"article-number":"555"}}